Trial record 1 of 2 for:
PRIMARY2 | Prostate Cancer
PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI (PRIMARY2)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05154162 |
|
Recruitment Status :
Recruiting
First Posted : December 10, 2021
Last Update Posted : July 28, 2023
|
Sponsor:
Peter MacCallum Cancer Centre, Australia
Collaborator:
St Vincent's Hospital, Sydney
Information provided by (Responsible Party):
Peter MacCallum Cancer Centre, Australia
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2027 |
| Estimated Study Completion Date : | March 2028 |